#retatrutide
8 stories
Woman warns retatrutide nearly killed her
TikTok user Lyndsey Jones says retatrutide dosing mistake left her paralyzed and near death.
LADbible · 1m
Eli Lilly Q2 2026 Revenue Surge
Lilly's Mounjaro revenue nearly doubled to $9.94 billion in Q2 2026, driving 48% revenue growth.
Alphastreet - Earnings Decoded. Market Intelligence Delivered · 1m
Eli Lilly's weight-loss drug shows strong results
An experimental drug from Eli Lilly called retatrutide produced significant weight loss in two new studies, outperforming existing medications.
TIME · 2m
Obesity drug cuts weight by 25 percent in trial
Retatrutide, a triple-acting hormone treatment from Eli Lilly, showed the strongest weight loss results yet in late-stage testing.
Ars Technica · 2m
Eli Lilly's Tough Month: Bank Predicts 37% Gains
Citi forecasts 37% stock gains for Eli Lilly as selloff ends.
24/7 Wall St. · 1m
Eli Lilly's $1500 Target Surprises Wall Street
Eli Lilly's revenue growth outpaces stock price, with analysts missing a $1500 target by 2027
24/7 Wall St. · 1m
Nvidia vs. Eli Lilly: Which Stock Wins Next Decade?
Nvidia's AI infrastructure and Eli Lilly's GLP-1 drugs both surged, but which stock has the cleaner path to 10-year growth?
24/7 Wall St. · 1m
Eli Lilly's unapproved weight loss drug sold illegally online
Retatrutide, still in clinical trials, is being marketed and sold to Americans through unauthorized online channels.
CBS News · 1m